ZA887478B - Novel controlled release formulations of tetracycline compounds - Google Patents

Novel controlled release formulations of tetracycline compounds

Info

Publication number
ZA887478B
ZA887478B ZA887478A ZA887478A ZA887478B ZA 887478 B ZA887478 B ZA 887478B ZA 887478 A ZA887478 A ZA 887478A ZA 887478 A ZA887478 A ZA 887478A ZA 887478 B ZA887478 B ZA 887478B
Authority
ZA
South Africa
Prior art keywords
controlled release
release formulations
tetracycline compounds
novel controlled
novel
Prior art date
Application number
ZA887478A
Other languages
English (en)
Inventor
Joseph J Valorose Jr
J Valorose Joseph Jr
Raymond J Biehl
J Biehl Raymond
Nitin V Sheth
V Sheth Nitin
Walter A Strathy
A Strathy Walter
Michael Kay Doelling
Kay Doelling Michael
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22303124&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA887478(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ZA887478B publication Critical patent/ZA887478B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA887478A 1987-10-06 1988-10-05 Novel controlled release formulations of tetracycline compounds ZA887478B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/104,917 US4837030A (en) 1987-10-06 1987-10-06 Novel controlled release formulations of tetracycline compounds

Publications (1)

Publication Number Publication Date
ZA887478B true ZA887478B (en) 1989-06-28

Family

ID=22303124

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA887478A ZA887478B (en) 1987-10-06 1988-10-05 Novel controlled release formulations of tetracycline compounds

Country Status (24)

Country Link
US (1) US4837030A (fr)
EP (1) EP0310814B1 (fr)
JP (1) JP2771189B2 (fr)
KR (1) KR970007902B1 (fr)
AR (1) AR243077A1 (fr)
AT (1) ATE120957T1 (fr)
AU (1) AU609525B2 (fr)
CA (1) CA1338439C (fr)
CZ (1) CZ279809B6 (fr)
DE (1) DE3853566T2 (fr)
DK (1) DK175578B1 (fr)
ES (1) ES2070837T3 (fr)
FI (1) FI97862C (fr)
GR (1) GR3015767T3 (fr)
HK (1) HK1000313A1 (fr)
HU (1) HU202110B (fr)
IL (1) IL87699A (fr)
NO (1) NO175619C (fr)
NZ (1) NZ226396A (fr)
PH (1) PH27236A (fr)
PL (1) PL275089A1 (fr)
PT (1) PT88664B (fr)
SK (1) SK656388A3 (fr)
ZA (1) ZA887478B (fr)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3887179T2 (de) * 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
US5211958A (en) * 1987-11-30 1993-05-18 Gist-Brocades, N.V. Pharmaceutical composition and process for its preparation
US5277916A (en) * 1988-02-01 1994-01-11 F. H. Faulding & Co., Ltd. Tetracycline dosage form
ES2060737T3 (es) * 1988-02-25 1994-12-01 Yamanouchi Europ Bv Procedimiento de preparacion de un granulado farmaceutico.
EP0418597A3 (en) * 1989-09-21 1991-11-27 American Cyanamid Company Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
ATE114472T1 (de) * 1989-09-21 1994-12-15 American Cyanamid Co System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
US5460825A (en) * 1990-05-23 1995-10-24 Mcneil-Ppc, Inc. Taste mask coatings for preparing chewable pharmaceutical tablets
US5260072A (en) * 1990-08-30 1993-11-09 Mcneil-Ppc, Inc. Rotogranulations and taste masking coatings for preparation of chewable pharmaceutical tablets
USRE40183E1 (en) 1991-10-04 2008-03-25 Wyeth Holdings Corporation 7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5494903A (en) 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
WO1993012768A1 (fr) * 1991-12-30 1993-07-08 Fmc Corporation Composition de spheronisation a base de cellulose microcristalline
US5262173A (en) * 1992-03-02 1993-11-16 American Cyanamid Company Pulsatile once-a-day delivery systems for minocycline
CA2093282C (fr) * 1992-05-04 1999-01-12 Tibor Sipos Dispositif d'administration intra-buccale de medicaments
US5614223A (en) * 1992-05-04 1997-03-25 Digestive Care Inc. Intraoral medicament-releasing device
US6224911B1 (en) * 1993-03-16 2001-05-01 Syntex (U.S.A.) Llc Process for the preparation of enteric coated pharmaceutical dosage forms
US5536507A (en) * 1994-06-24 1996-07-16 Bristol-Myers Squibb Company Colonic drug delivery system
US20030215507A1 (en) * 1996-03-25 2003-11-20 Wyeth Extended release formulation
US20060073201A1 (en) * 1996-03-25 2006-04-06 Wyeth Extended release formulation
US6230052B1 (en) 1999-01-29 2001-05-08 Andy Wolff Device and method for stimulating salivation
AU5139600A (en) * 1999-05-27 2000-12-18 Drugtech Corporation Nutritional formulations
US20050037065A1 (en) * 1999-05-27 2005-02-17 Drugtech Corporation Nutritional formulations
KR100982753B1 (ko) * 2001-04-05 2010-09-16 콜라제넥스 파마슈티칼스, 인크 테트라사이클린 화합물 및 테트라사이클린 유도체의 전달조절
US20030133982A1 (en) * 2001-12-20 2003-07-17 Heimlich John M. Zero-order sustained release dosage forms and method of making same
AU2003213876B2 (en) * 2002-04-12 2006-10-12 Mayne Pharma International Pty Ltd An improved modified release preparation
US6958161B2 (en) * 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
AUPS167602A0 (en) * 2002-04-12 2002-05-16 F.H. Faulding & Co. Limited An improved modified release preparation
WO2004041244A2 (fr) * 2002-10-30 2004-05-21 Pharmacia Corporation Comprimes oraux a liberation etendue et procedes de fabrication et d'utilisation associes
US20040158194A1 (en) * 2003-02-06 2004-08-12 Wolff Andy And Beiski Ben Z. Oral devices and methods for controlled drug release
US7749532B2 (en) 2003-04-07 2010-07-06 Supernus Pharmaceuticals, Inc. Once daily formulations of tetracyclines
GB2414668B (en) * 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
WO2006078925A2 (fr) * 2005-01-21 2006-07-27 Warner Chilcott Company, Inc. Complexe metallique de tetracycline sous forme de dosage solide
BRPI0607110B1 (pt) * 2005-02-04 2016-06-28 Philip Morris Products Sa cigarro compreendendo um bastão de tabaco e um filtro multicomponente
US20070106138A1 (en) * 2005-05-26 2007-05-10 Beiski Ben Z Intraoral apparatus for non-invasive blood and saliva monitoring & sensing
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
CA2632213A1 (fr) * 2005-12-22 2007-07-05 Wyeth Formulations orales contenant de la tigecycline
US20070166273A1 (en) * 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
JP5527921B2 (ja) * 2006-12-22 2014-06-25 エスエス製薬株式会社 苦味を隠蔽した経口固形組成物
ITMI20070022A1 (it) 2007-01-09 2008-07-10 I P S Internat Products & Services Srl Formulazione di prodotti solidi a rilascio controllato per uso orale in bustine monodose e relativo procedimento di preparazione
JP5395052B2 (ja) * 2007-03-23 2014-01-22 モレキュラー リサーチ センター インコーポレイテッド 炎症を処置するための組成物および方法
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
WO2010017310A1 (fr) * 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Procédé pour le traitement de l'acné, et certaines formes posologiques de celui-ci
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
EP2814466B1 (fr) * 2012-02-15 2018-12-26 Takeda Pharmaceutical Company Limited Comprimé comprenant 1-(4-methoxybutyl)-n-(2-methylpropyl)-n-[(3s,5r)-5-(morpholin-4-ylcarbonyl)piperidin-3-yl]-1h-benzimidazole-2-carboxamide ou son sel
PT2968174T (pt) 2013-03-15 2020-01-15 Braintree Laboratories Inc Comprimidos de duplo uso oral em composições farmacêuticas de sais de sulfato e seus métodos de utilização
US20170182070A1 (en) 2014-10-08 2017-06-29 Mayne Pharma International Pty Ltd. Controlled Release Doxycycline
US11103517B2 (en) 2015-04-07 2021-08-31 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for minocycline
IL273038B (en) 2020-03-03 2022-02-01 Ben Zion Karmon bone graft

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148212A (en) * 1961-12-22 1964-09-08 American Cyanamid Co Reductive alkylation process
USRE26253E (en) * 1963-05-17 1967-08-15 And z-alkylamino-g-deoxytetracycline
US3356571A (en) * 1964-11-25 1967-12-05 American Cyanamid Co Potentiation of tetracycline by polyacrylic acid or hydrolyzed polyacrylonitrile
CH434571A (de) * 1966-07-05 1967-04-30 Chemical And Pharmaceutical Pa Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung
CH434240A (de) * 1965-12-30 1967-04-30 Chemical And Pharmaceutical Pa Verfahren zur Herstellung einer therapeutischen Tetracyclinzubereitung mit verlängerter therapeutischer Wirkung
IT1050353B (it) * 1966-01-06 1981-03-10 Ceskoslovenska Akademie Ved Supporti per sostanze biologigamente attive
US4207258A (en) * 1972-02-24 1980-06-10 Ankerfarm S.P.A. Process for the preparatin of α-6-deoxytetracyclines
FR2183546B1 (fr) * 1972-05-10 1975-06-20 Servier Lab
US4038315A (en) * 1972-05-11 1977-07-26 American Cyanamid Company Isolation and recovery of calcium chloride complex of 7-dimethylamino-6-dimethyl l-6-deoxytetracycline hydrochloride
CH582002A5 (fr) * 1972-06-09 1976-11-30 Purdue Research Foundation
NL158172B (nl) * 1972-09-18 1978-10-16 Farmaceutici Italia Werkwijze voor het bereiden van tetracyclinederivaten met een substituent op de 7-plaats.
JPS4941522A (fr) * 1973-05-17 1974-04-18
GB1413186A (en) * 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
US4088798A (en) * 1975-11-11 1978-05-09 Sandoz, Inc. Methods for the preparation of controlled gastric residence time medicament formulations
US4154827A (en) * 1977-12-15 1979-05-15 University Of Pennsylvania Inhibition of ADH-stimulated osmotic water flow and aldosterone-stimulated sodium transport
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4622244A (en) * 1979-09-04 1986-11-11 The Washington University Process for preparation of microcapsules
ES511731A0 (es) * 1981-06-01 1983-07-01 Orion Yhtymae Oy "un metodo para preparar tabletas a base de polvos de medicamento acidicos, inocuas para el esofago".
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4500458A (en) * 1982-01-19 1985-02-19 Plurichemie Anstalt Process for the preparation of α-6-deoxytetracyclines
US4701320A (en) * 1984-11-29 1987-10-20 Lederle (Japan), Ltd. Composition stably containing minocycline for treating periodontal diseases

Also Published As

Publication number Publication date
HU202110B (en) 1991-02-28
NZ226396A (en) 1991-08-27
IL87699A0 (en) 1989-02-28
FI884575A (fi) 1989-04-07
FI97862B (fi) 1996-11-29
ATE120957T1 (de) 1995-04-15
PT88664B (pt) 2003-06-30
EP0310814A3 (en) 1989-05-03
FI97862C (fi) 1997-03-10
KR970007902B1 (ko) 1997-05-17
HK1000313A1 (en) 1998-02-27
EP0310814B1 (fr) 1995-04-12
AU2344488A (en) 1989-04-06
IL87699A (en) 1994-06-24
PH27236A (en) 1993-05-04
FI884575A0 (fi) 1988-10-05
ES2070837T3 (es) 1995-06-16
JP2771189B2 (ja) 1998-07-02
NO175619C (no) 1994-11-09
US4837030A (en) 1989-06-06
JPH01128929A (ja) 1989-05-22
AU609525B2 (en) 1991-05-02
DK175578B1 (da) 2004-12-13
SK278567B6 (en) 1997-10-08
KR890006242A (ko) 1989-06-12
PT88664A (pt) 1989-07-31
CZ279809B6 (cs) 1995-07-12
DE3853566D1 (de) 1995-05-18
AR243077A1 (es) 1993-07-30
DK556788D0 (da) 1988-10-05
NO884408L (no) 1989-04-07
GR3015767T3 (en) 1995-07-31
SK656388A3 (en) 1997-10-08
NO175619B (fr) 1994-08-01
DK556788A (da) 1989-04-07
NO884408D0 (no) 1988-10-05
CZ656388A3 (en) 1995-02-15
HUT50046A (en) 1989-12-28
EP0310814A2 (fr) 1989-04-12
DE3853566T2 (de) 1996-01-11
CA1338439C (fr) 1996-07-09
PL275089A1 (en) 1989-07-10

Similar Documents

Publication Publication Date Title
AR243077A1 (es) Procedimiento para la produccion de una composicion farmaceutica esferonizada de liberacion controlada de compuestos de tetraciclina.
KR960013701B1 (en) Process for preparation of controlled release formulations
GB2207353B (en) Controlled release formulation
KR960009650B1 (en) Sustained release pharmaceutical composition of diltiazem
GR880100491A (en) Method for the preparation of aketaminophane formulations orally slowly released
EP0251459A3 (en) Controlled release pharmaceutical composition
GR880100618A (en) Constant formulations containing growing agents
GB8724763D0 (en) Sustained-release formulations
EG18523A (en) Substained release matrix formulations
IL78859A (en) Preparation of slow release compositions
IL72041A0 (en) Preparation for controlled release of iodine
IE883011L (en) Novel controlled release formulations of tetracycline compounds
GB8712396D0 (en) Composition of matter
GB8521221D0 (en) Controlled release formulations
ZA896012B (en) Controlled release formulations
GB8724163D0 (en) Preparation of controlled release pharmaceutical composition
IE861214L (en) Compositions for the preparation of micro-particles for¹prolonged release
GB8802972D0 (en) Triperfluoroalkylamines & preparation of same
GB8922061D0 (en) Controlled release formulations
AU589254C (en) Slow release formulations
IE871503L (en) Sustained release formulations
IE821073L (en) Slow release formulations of pheromones
EG17797A (en) Controlled release formulation
IE863030L (en) Controlled release composition
GR870097B (en) Composition of polyunsaturated aliphatic compounds